Using the same approach but a different FABP4/aP2-Cre transgene, Jones et al. also found that compared with wild-type animals, mice with adipocyte-specific PPARγ ablation had decreased weight gain, WAT mass, and adipokine levels when fed an HFD, together with WAT inflammation and fibrosis and fatty liver [132]. This evidence concerns the gene FABP4 and fatty liver disease.